Supplemental Subsidiary Guarantors (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Jan. 31, 2014	Jan. 25, 2013	Oct. 25, 2013	Oct. 26, 2012
Condensed Consolidating Statement of Income
Net sales	$ 839,312	$ 1,149,877
Cost of sales	604,178	773,149
Product development, selling and administrative expenses	153,029	157,281
Other (income) expense, net	(3,140)	(1,705)
Operating income	85,245	221,152
Income from continuing operations before income taxes	71,425	205,999
Provision for income taxes	22,564	63,860
Income from continuing operations	48,861	142,139
Comprehensive income	2,403	145,367
Current assets:
Cash and cash equivalents	290,899	269,895
Accounts receivable, net	953,792		1,083,663
Inventories	1,135,112		1,139,744
Other current assets	208,031		193,328
Total current assets	2,587,834		2,822,444
Property, plant and equipment, net	897,884		912,642
Other assets:
Other intangible assets, net	325,572		331,812
Goodwill	1,479,321		1,480,519
Deferred income taxes	37,723		41,532
Other non-current assets	195,342		200,633
Total other assets	2,037,958		2,054,496
Total assets	5,523,676	6,176,798	5,789,582
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	58,356		58,669
Trade accounts payable	283,969		388,119
Employee compensation and benefits	95,766		130,555
Advance payments and progress billings	472,846		399,768
Accrued warranties	77,804	87,427	85,732	100,646
Other accrued liabilities	243,088		286,063
Current liabilities of discontinued operations	11,684		11,684
Total current liabilities	1,243,513		1,360,590
Long-term obligations	1,243,874		1,256,927
Other liabilities:
Liabilities for postretirement benefits	20,319		20,723
Accrued pension costs	144,321		149,805
Other non-current liabilities	146,610		143,168
Total other liabilities	311,250		313,696
Shareholders’ equity	2,725,039		2,858,369
Total liabilities and shareholders’ equity	5,523,676		5,789,582
Operating Activities:
Net cash provided (used) by operating activities of continuing operations	64,839	92,065
Net cash provided (used) by operating activities of discontinued operations	67	(1,571)
Net cash provided by operating activities	64,906	90,494
Investing Activities:
Property, plant and equipment acquired	(26,655)	(54,588)
Proceeds from sale of property, plant and equipment	2,081	1,053
Other investing activities, net	(21)	1,793
Net cash used by investing activities	(24,595)	(51,742)
Financing Activities:
Common stock issued	1,985	3,012
Excess tax (detriment) benefit from share-based compensation awards	(284)	1,522
Dividends paid	(17,850)	(18,542)
Repayments of term loan	(12,500)	(12,500)
Change in short and other long-term obligations, net	(1,259)	(4,702)
Treasury stock purchased	(122,036)	0
Net cash used by financing activities	(151,944)	(31,210)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(3,177)	(1,520)
(Decrease) Increase in Cash and Cash Equivalents	(114,810)	6,022
Cash and Cash Equivalents at Beginning of Period	405,709	263,873
Cash and Cash Equivalents at End of Period	290,899	269,895
Parent Company
Condensed Consolidating Statement of Income
Net sales	0	0
Cost of sales	0	0
Product development, selling and administrative expenses	14,669	12,802
Other (income) expense, net	(473)	0
Operating income	(14,196)	(12,802)
Intercompany items	17,278	31,120
Interest (expense) income, net	(16,045)	(22,570)
Income from continuing operations before income taxes	(12,963)	(4,252)
Provision for income taxes	(5,054)	(9,276)
Equity in income of subsidiaries	56,770	137,115
Income from continuing operations	48,861	142,139
Comprehensive income	2,403	145,367
Current assets:
Cash and cash equivalents	29,665	26,993
Accounts receivable, net	0		0
Inventories	0		0
Other current assets	72,409		68,792
Total current assets	102,074		191,693
Property, plant and equipment, net	20,885		18,081
Other assets:
Other intangible assets, net	0		0
Goodwill	0		0
Deferred income taxes	(33,294)		(49,393)
Other non-current assets	4,113,404		4,168,916
Total other assets	4,080,110		4,119,523
Total assets	4,203,069		4,329,297
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	50,000		50,000
Trade accounts payable	731		2,565
Employee compensation and benefits	8,497		10,080
Advance payments and progress billings	0		0
Accrued warranties	0		0
Other accrued liabilities	38,454		24,545
Current liabilities of discontinued operations	0		0
Total current liabilities	97,682		87,190
Long-term obligations	1,243,860		1,256,164
Other liabilities:
Liabilities for postretirement benefits	19,471		19,881
Accrued pension costs	131,673		136,886
Other non-current liabilities	(14,656)		(29,193)
Total other liabilities	136,488		127,574
Shareholders’ equity	2,725,039		2,858,369
Total liabilities and shareholders’ equity	4,203,069		4,329,297
Operating Activities:
Net cash provided (used) by operating activities of continuing operations	61,014	51,491
Net cash provided (used) by operating activities of discontinued operations	0	0
Net cash provided by operating activities	61,014	51,491
Investing Activities:
Property, plant and equipment acquired	(3,544)	(1,417)
Proceeds from sale of property, plant and equipment	0	0
Other investing activities, net	(21)	(32)
Net cash used by investing activities	(3,565)	(1,449)
Financing Activities:
Common stock issued	1,985	3,012
Excess tax (detriment) benefit from share-based compensation awards	(284)	1,522
Dividends paid	(17,850)	(18,542)
Repayments of term loan	(12,500)	(12,500)
Change in short and other long-term obligations, net	0	0
Treasury stock purchased	(122,036)
Net cash used by financing activities	(150,685)	(26,508)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0	0
(Decrease) Increase in Cash and Cash Equivalents	(93,236)	23,534
Cash and Cash Equivalents at Beginning of Period	122,901	3,459
Cash and Cash Equivalents at End of Period	29,665	26,993
Subsidiary Guarantors
Condensed Consolidating Statement of Income
Net sales	478,576	600,956
Cost of sales	361,369	410,643
Product development, selling and administrative expenses	67,591	74,117
Other (income) expense, net	2,330	9,176
Operating income	47,286	107,020
Intercompany items	(19,986)	(19,848)
Interest (expense) income, net	1,854	97
Income from continuing operations before income taxes	29,154	87,269
Provision for income taxes	27,256	57,046
Equity in income of subsidiaries	33,013	92,701
Income from continuing operations	34,911	122,924
Comprehensive income	33,376	121,201
Current assets:
Cash and cash equivalents	6,580	3,584
Accounts receivable, net	390,404		402,321
Inventories	455,890		456,345
Other current assets	8,799		16,957
Total current assets	861,673		895,984
Property, plant and equipment, net	363,273		373,235
Other assets:
Other intangible assets, net	242,456		247,200
Goodwill	454,199		454,199
Deferred income taxes	0		0
Other non-current assets	1,800,826		2,070,239
Total other assets	2,497,481		2,771,638
Total assets	3,722,427		4,040,857
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	0		449
Trade accounts payable	138,347		165,045
Employee compensation and benefits	42,910		52,260
Advance payments and progress billings	162,715		144,853
Accrued warranties	27,281		30,111
Other accrued liabilities	49,851		54,285
Current liabilities of discontinued operations	11,684		11,684
Total current liabilities	432,788		458,687
Long-term obligations	0		763
Other liabilities:
Liabilities for postretirement benefits	848		842
Accrued pension costs	5,502		5,685
Other non-current liabilities	8,169		7,851
Total other liabilities	14,519		14,378
Shareholders’ equity	3,275,120		3,567,029
Total liabilities and shareholders’ equity	3,722,427		4,040,857
Operating Activities:
Net cash provided (used) by operating activities of continuing operations	(9,829)	15,201
Net cash provided (used) by operating activities of discontinued operations	67	(1,571)
Net cash provided by operating activities	(9,762)	13,630
Investing Activities:
Property, plant and equipment acquired	(4,084)	(14,081)
Proceeds from sale of property, plant and equipment	1,277	(2,489)
Other investing activities, net	0	0
Net cash used by investing activities	(2,807)	(16,570)
Financing Activities:
Common stock issued	0	0
Excess tax (detriment) benefit from share-based compensation awards	0	0
Dividends paid	0	0
Repayments of term loan	0	0
Change in short and other long-term obligations, net	(1,212)	(104)
Treasury stock purchased	0
Net cash used by financing activities	(1,212)	(104)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0	0
(Decrease) Increase in Cash and Cash Equivalents	(13,781)	(3,044)
Cash and Cash Equivalents at Beginning of Period	20,361	6,628
Cash and Cash Equivalents at End of Period	6,580	3,584
Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Income
Net sales	604,861	877,521
Cost of sales	447,537	621,120
Product development, selling and administrative expenses	70,769	70,362
Other (income) expense, net	(4,997)	(10,881)
Operating income	91,552	196,920
Intercompany items	(9,071)	(35,657)
Interest (expense) income, net	371	7,320
Income from continuing operations before income taxes	82,852	168,583
Provision for income taxes	362	16,090
Equity in income of subsidiaries	0	0
Income from continuing operations	82,490	152,493
Comprehensive income	34,786	149,000
Current assets:
Cash and cash equivalents	254,654	239,318
Accounts receivable, net	571,903		687,790
Inventories	804,206		813,182
Other current assets	126,808		107,564
Total current assets	1,757,571		1,870,983
Property, plant and equipment, net	513,726		521,326
Other assets:
Other intangible assets, net	83,116		84,612
Goodwill	1,025,122		1,026,320
Deferred income taxes	71,017		90,925
Other non-current assets	2,617,174		3,963,205
Total other assets	3,796,429		5,165,062
Total assets	6,067,726		7,557,371
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	8,356		8,220
Trade accounts payable	144,891		220,509
Employee compensation and benefits	44,359		68,215
Advance payments and progress billings	331,384		269,628
Accrued warranties	50,523		55,621
Other accrued liabilities	158,414		211,074
Current liabilities of discontinued operations	0		0
Total current liabilities	737,927		833,267
Long-term obligations	14		0
Other liabilities:
Liabilities for postretirement benefits	0		0
Accrued pension costs	7,146		7,234
Other non-current liabilities	153,097		164,510
Total other liabilities	160,243		171,744
Shareholders’ equity	5,169,542		6,552,360
Total liabilities and shareholders’ equity	6,067,726		7,557,371
Operating Activities:
Net cash provided (used) by operating activities of continuing operations	13,654	25,373
Net cash provided (used) by operating activities of discontinued operations	0	0
Net cash provided by operating activities	13,654	25,373
Investing Activities:
Property, plant and equipment acquired	(19,027)	(39,090)
Proceeds from sale of property, plant and equipment	804	3,542
Other investing activities, net	0	1,825
Net cash used by investing activities	(18,223)	(33,723)
Financing Activities:
Common stock issued	0	0
Excess tax (detriment) benefit from share-based compensation awards	0	0
Dividends paid	0	0
Repayments of term loan	0	0
Change in short and other long-term obligations, net	(47)	(4,598)
Treasury stock purchased	0
Net cash used by financing activities	(47)	(4,598)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(3,177)	(1,520)
(Decrease) Increase in Cash and Cash Equivalents	(7,793)	(14,468)
Cash and Cash Equivalents at Beginning of Period	262,447	253,786
Cash and Cash Equivalents at End of Period	254,654	239,318
Eliminations
Condensed Consolidating Statement of Income
Net sales	(244,125)	(328,600)
Cost of sales	(204,728)	(258,614)
Product development, selling and administrative expenses	0	0
Other (income) expense, net	0	0
Operating income	(39,397)	(69,986)
Intercompany items	11,779	24,385
Interest (expense) income, net	0	0
Income from continuing operations before income taxes	(27,618)	(45,601)
Provision for income taxes	0	0
Equity in income of subsidiaries	(89,783)	(229,816)
Income from continuing operations	(117,401)	(275,417)
Comprehensive income	(68,162)	(270,201)
Current assets:
Cash and cash equivalents	0
Accounts receivable, net	(8,515)		(6,448)
Inventories	(124,984)		(129,783)
Other current assets	15		15
Total current assets	(133,484)		(136,216)
Property, plant and equipment, net	0		0
Other assets:
Other intangible assets, net	0		0
Goodwill	0		0
Deferred income taxes	0		0
Other non-current assets	(8,336,062)		(10,001,727)
Total other assets	(8,336,062)		(10,001,727)
Total assets	(8,469,546)		(10,137,943)
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	0		0
Trade accounts payable	0		0
Employee compensation and benefits	0		0
Advance payments and progress billings	(21,253)		(14,713)
Accrued warranties	0		0
Other accrued liabilities	(3,631)		(3,841)
Current liabilities of discontinued operations	0		0
Total current liabilities	(24,884)		(18,554)
Long-term obligations	0		0
Other liabilities:
Liabilities for postretirement benefits	0		0
Accrued pension costs	0		0
Other non-current liabilities	0		0
Total other liabilities	0		0
Shareholders’ equity	(8,444,662)		(10,119,389)
Total liabilities and shareholders’ equity	(8,469,546)		(10,137,943)
Financing Activities:
Cash and Cash Equivalents at Beginning of Period	0
Cash and Cash Equivalents at End of Period	0
Consolidated
Condensed Consolidating Statement of Income
Net sales	839,312	1,149,877
Cost of sales	604,178	773,149
Product development, selling and administrative expenses	153,029	157,281
Other (income) expense, net	(3,140)	(1,705)
Operating income	85,245	221,152
Intercompany items	0	0
Interest (expense) income, net	(13,820)	(15,153)
Income from continuing operations before income taxes	71,425	205,999
Provision for income taxes	22,564	63,860
Equity in income of subsidiaries	0	0
Income from continuing operations	48,861	142,139
Comprehensive income	2,403	145,367
Current assets:
Cash and cash equivalents	290,899	269,895
Accounts receivable, net	953,792		1,083,663
Inventories	1,135,112		1,139,744
Other current assets	208,031		193,328
Total current assets	2,587,834		2,822,444
Property, plant and equipment, net	897,884		912,642
Other assets:
Other intangible assets, net	325,572		331,812
Goodwill	1,479,321		1,480,519
Deferred income taxes	37,723		41,532
Other non-current assets	195,342		200,633
Total other assets	2,037,958		2,054,496
Total assets	5,523,676		5,789,582
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	58,356		58,669
Trade accounts payable	283,969		388,119
Employee compensation and benefits	95,766		130,555
Advance payments and progress billings	472,846		399,768
Accrued warranties	77,804		85,732
Other accrued liabilities	243,088		286,063
Current liabilities of discontinued operations	11,684		11,684
Total current liabilities	1,243,513		1,360,590
Long-term obligations	1,243,874		1,256,927
Other liabilities:
Liabilities for postretirement benefits	20,319		20,723
Accrued pension costs	144,321		149,805
Other non-current liabilities	146,610		143,168
Total other liabilities	311,250		313,696
Shareholders’ equity	2,725,039		2,858,369
Total liabilities and shareholders’ equity	5,523,676		5,789,582
Operating Activities:
Net cash provided (used) by operating activities of continuing operations	64,839	92,065
Net cash provided (used) by operating activities of discontinued operations	67	(1,571)
Net cash provided by operating activities	64,906	90,494
Investing Activities:
Property, plant and equipment acquired	(26,655)	(54,588)
Proceeds from sale of property, plant and equipment	2,081	1,053
Other investing activities, net	(21)	1,793
Net cash used by investing activities	(24,595)	(51,742)
Financing Activities:
Common stock issued	1,985	3,012
Excess tax (detriment) benefit from share-based compensation awards	(284)	1,522
Dividends paid	(17,850)	(18,542)
Repayments of term loan	(12,500)	(12,500)
Change in short and other long-term obligations, net	(1,259)	(4,702)
Treasury stock purchased	(122,036)
Net cash used by financing activities	(151,944)	(31,210)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(3,177)	(1,520)
(Decrease) Increase in Cash and Cash Equivalents	(114,810)	6,022
Cash and Cash Equivalents at Beginning of Period	405,709	263,873
Cash and Cash Equivalents at End of Period	$ 290,899	$ 269,895